Febit holding GmbH' Patents
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Febit holding GmbH' Patents - overview
Location
-, -, Germany
Primary Industry
Biotechnology
About
Based in Germany, Febit holding GmbH' Patents is part of is a provider of miRNA and mRNA solutions for enabling biochip applications in life sciences. In September 2012, Synthetic Genomics Inc, a portfolio company of Draper Fisher Jurvetson, Frontier Venture Capital, Biotechonomy acquired Febit holding GmbH' Patents from Febit Holding GmbH and In-Q-Tel. Febit holding GmbH' Patents specializes in synthetic genomic technologies that includes oligonucleotide synthesis and retrieval of sequence-validated DNA. The company focuses on improving development and commercialization of a variety of products including algae-based food and nutritional products, biofuels, biochemicals, synthetic vaccines and clean water.
Current Investors
Viridos
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Bioinformatics
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.